Trials / Completed
CompletedNCT05229952
Assessment of Endogenous Oxalate Synthesis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 23 (actual)
- Sponsor
- University of Alabama at Birmingham · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
This study aims to determine the daily rate of endogenous synthesis of oxalate using carbon 13 oxalate isotope tracer technique and a low-oxalate controlled diet.
Detailed description
Urinary oxalate excretion is derived from both dietary sources and endogenous synthesis. This study will use low-oxalate controlled diet and intravenous infusion of the isotope tracer carbon 13 oxalate, timed with blood and urine collections, to determine the daily rate of endogenous oxalate synthesis in non-stone forming volunteers and in subjects with calcium oxalate kidney stones. A DXA scan will be used to assess body composition.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Low-oxalate controlled diet | Participants will consume a diet that is controlled in its contents of protein, carbohydrates, fat, calcium, oxalate, vitamin C and sodium for 5 days. Participants will be asked not to take any dietary supplements, exercise strenuously, or consume food or drink that is not provided to them. |
| OTHER | Primed, continuous intravenous infusion of 13C2-oxalate | Participants will receive a continuous intravenous administration of carbon-13 oxalate, a naturally occurring form of oxalate, over the course of several hours until steady-state is achieved, using an IV catheter, while remaining fasting. |
Timeline
- Start date
- 2022-02-10
- Primary completion
- 2024-09-09
- Completion
- 2024-09-09
- First posted
- 2022-02-08
- Last updated
- 2025-05-13
- Results posted
- 2024-12-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05229952. Inclusion in this directory is not an endorsement.